Medical Devices
Technology
Health

Varian

$128.79
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.87 (0.68%) Today
+$0.72 (0.56%) After Hours

Why Robinhood?

You can buy or sell Varian and other stocks, options, ETFs, and crypto commission-free!

About

Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical conditions. It operates through the Oncology Systems and Proton Solutions segments. Read More The Oncology Systems segment designs, manufactures, sells, and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments. The Proton Solutions segment delivers proton therapy, a form of external beam radiotherapy using proton beams for the treatment of cancer. The company was founded by William Hansen, Edward Ginzton, Russell Varian, and Sigurd Varian in 1948 and is headquartered in Palo Alto, CA.

Employees
7,174
Headquarters
Palo Alto, California
Founded
1948
Market Cap
11.60B
Price-Earnings Ratio
30.98
Dividend Yield
0.00
Average Volume
672.40K
High Today
$129.36
Low Today
$127.16
Open Price
$128.06
Volume
167.39K
52 Week High
$142.50
52 Week Low
$101.42

Collections

Medical Devices
Technology
Health
Medical
Cancer Prevention
Software Service
Therapy
US

News

Seeking Alpha16h

Varian Medical Systems To Acquire Cancer Treatment Services For India Cancer Data

With the deal, VAR is gaining direct access to patient treatment data which it will use to inform its cancer product development.

8
Yahoo FinanceMay 21

Varian Medical's CTSI Buyout to Boost Oncology Services Unit

Varian Medical Systems, Inc. VAR recently entered into a definitive agreement to acquire Cancer Treatment Services International (“CTSI”) for $283 million. The collaboration is expected to boost Varian Medical’s core Oncology Systems business. More on the Deal Varian Medical expects the deal to have a 6-cent-per-share-dilutive impact on earnings on a reported basis and 3 cents on an adjusted basis. Varian Medical also expects the buyout to be accretive to earnings per share during fiscal 2021 on an adjust...

9
Seeking AlphaMay 20

Varian Medical scoops up CTSI for $283M

Varian Medical Systems agrees to acquire privately held Cancer Treatment Services International or CTSI for $283M. The transaction is expected to increase Varian's expertise in cancer center operations, as well as expand the scope and geographic reach of CTSI's technology-enabled clinical solutions. CTSI generated annual revenues of $43.5M and Varian expects the acquisition to be accretive to EPS in FY2021 on non-GAAP basis and FY2022 on GAAP basis. VAR is adjusting its FY19 annual guidance given the pro...

28

Earnings

$0.98
$1.06
$1.13
$1.21
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Jul 24, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.